Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia (Q66392909)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia |
clinical trial |
Statements
Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia (English)
0 references
16 December 2016
0 references
2 April 2019
0 references
10
0 references
18 year
0 references
99 year
0 references